A simple approach for estimating gene expression in Candida albicans directly from a systemic infection site

Journal of Infectious Diseases

Volumn 192, Issue 5, 2005, Pages 893-900

  Andes, David ^a,b,c   Lepak, A ^a   Pitula, A ^a   Marchillo, K ^a   Clark, J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

ANIMAL CELL; ARTICLE; CANDIDA ALBICANS; CELL WALL; CONTROLLED STUDY; CYTOLYSIS; DNA MICROARRAY; FUNGAL CELL; GENE EXPRESSION REGULATION; HOST PATHOGEN INTERACTION; HYPOTHESIS; IN VIVO STUDY; INFECTION RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA ISOLATION; SYSTEMIC DISEASE;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; CELL WALL; DNA, FUNGAL; GENE EXPRESSION; HUMANS; KIDNEY; MICE; MICE, INBRED ICR; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEASES; RNA, FUNGAL; UP-REGULATION;

EID: 23944518475     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/432104     Document Type: Article

References (26)

1. Altamura M, Casale D, Pepe M, Tafaro A. Immune responses to fungal infections and therapeutic implications. Curr Drug Targets Immune Endocr Metabol Disord 2001; 1:189-97.
2. Ishibashi K, Miura NN, Adachi Y, et al. DNA array analysis of altered gene expression in human leukocytes stimulated with soluble and particulate forms of Candida cell wall β-glucan. Int Immunopharmacol 2004; 4:387-401.
3. Mullick A, Elias M, Harakidas P, et al. Gene expression in HL60 granulocytoids and human polymorphonuclear leukocytes exposed to Candida albicans. Infect Immun 2004; 72:414-29.
4. MICROBEnrich Kit. Manual version 0408. Austin: Ambion.
5. Hinton JCD, Hautefort I, Eriksson S, Thompson A, Rhen M. Benefits and pitfalls of using microarrays to monitor bacterial gene expression during infection. Curr Opin Microbiol 2004; 7:277-82.
6. Fradin C, Kretschmar M, Nichterlein T, Gaillardin C, d'Enfert D, Hube B. Stage-specific gene expression of Candida albicans in human blood. Mol Microbiol 2003;47:1523-43.
7. Lorenz MC, Fink GR. The glyoxylate cycle is required for fungal virulence. Nature 2001;412:83-6.
8. Naglik JR, Newport G, White TC, et al. In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis. Infect Immun 1999;67:2482-90.
9. Rubin-Bejerano I, Fraser I, Grisafi P, Fink GR. Phagocytosis by neutrophils induces an amino acid deprivation response in Saccharomyces cerevisiae and Candida albicans. Proc Natl Acad Sci 2003; 100:11007-12.
10. Ioannou YA, Chen FW. Quantitation of DNA fragmentation in apoptosis. Nucl Acids Res 1996; 24:992-3.
11. Kohrer K, Domdey H. Preparation of high molecular weight RNA. Methods Enzymol 1991; 194:398-405.
12. Mueller O, Lightfoot S, Schroeder A. RNA integrity number-standardization of RNA quality control [publication no. 5989-1165EN]. Agilent Application Note. Palo Alto, CA: Agilent Technologies, 2004.
13. Sabath DE, Broome HE, Prystowsky MB. Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloud T-helper lymphocyte. Gene 1990; 91:185-91.
14. Losberger C, Ernst JF. Sequence of Candida albicans gene encoding actin. Nucl Acids Res 1989; 17:9488.
15. Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000; 25:169-93.
16. Sanglard D, Ischer R, Monod M, Bille J. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter. Microbiology 1997; 143: 405-16.
17. Prasad R, De Wergifosse P, Goffeau A, Balzi E. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drug and antifungals. Curr Genet 1995; 27:320-9.
18. Lyons CN, White TC. Transcriptional analyses of antifungal drug resistance in Candida albicans. Antimicrob Agents Chemother 2000; 44: 2296-303.
19. Krishnamurthy S, Gupta V, Prasad R, Panwar SL, Prasad R. Expression of CDR1, a multidrug resistance gene of Candida albicans: transcriptional activation by heat shock, drugs and human steroid hormones. FEMS Microbiol Lett 1998; 160:191-7.
20. Livak KJ, Flood SJ, Marmaro J, Giusti W, Deetz K. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl 1995; 4:357-62.
21. ΔΔCT method. Methods 2001; 25:402-8.
22. Cowen LE, Nantel A, Whiteway MS, et al. Population genomics of drug resistance in Candida albicans. Proc Natl Acad Sci USA 2002; 99: 9284-9.
23. Dozois CM, Daigle F, Curtiss R 3rd. Identification of pathogen-specific and conserved genes expressed in vivo by an avian pathogenic Escherichia coli strain. Proc Natl Acad Sci USA 2003; 100:247-52.
24. Xu Q, Dziejman M, Mekalanos JJ. Determination of the transcriptome of Vibrio cholerae during intraintestinal growth and midexponential phase in vitro. Proc Natl Acad Sci USA 2003; 100:1286-91.
25. Zhu G, Xiao H, Mohan VP, et al. Gene expression in the tuberculous granuloma: analysis by laser capture microdissection and real-time PCR. Cell Microbiol 2003; 5:445-53.
26. Pappas PG, Rex JH, Sobel JD, et al. Guidelines for treatment of candidiasis. Clin Infect Dis 2004; 38:161-89.